@ArgaizR @load_dependent Excerpt from the text:
1/3 "While nitroprusside has been recommended as the afterload agent of choice in both lesions, this is likely of somewhat historical context given its evaluation in initial studies in the 1970s. It is likely that most intravenous afterload reducing agents
1/3 "While nitroprusside has been recommended as the afterload agent of choice in both lesions, this is likely of somewhat historical context given its evaluation in initial studies in the 1970s. It is likely that most intravenous afterload reducing agents
@ArgaizR @load_dependent 2/3
will work in these scenarios, including isoproterenol for acute AR with low heart rates, intravenous Ξ²-blockers in Type A aortic dissection and intravenous nitroglycerin for patients with concomitant ischemia. For patients with persistent hypotension, inotropes should be
will work in these scenarios, including isoproterenol for acute AR with low heart rates, intravenous Ξ²-blockers in Type A aortic dissection and intravenous nitroglycerin for patients with concomitant ischemia. For patients with persistent hypotension, inotropes should be
@ArgaizR @load_dependent 3/4 considered. While there is no clear βdrug of choiceβ should additional vasopressors be required, norepinephrine is associated with fewer arrhythmias and is often utilized as a first-line pressor in cardiogenic shock.
@ArgaizR @load_dependent 4/4
Dopamine and epinephrine may also be considered depending on the clinical scenario, although notably, both have been associated with adverse outcomes in subgroups of patients with cardiogenic shock
Dopamine and epinephrine may also be considered depending on the clinical scenario, although notably, both have been associated with adverse outcomes in subgroups of patients with cardiogenic shock
@ArgaizR @load_dependent Dobutamine not mentioned.
Loading suggestions...